Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...

The stock's fall snapped a three-day winning streak.

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The new funding will support the commercial launch of the company's at-home screening test for colorectal cancer, as well as ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line ...

In the preceding three months, 8 analysts have released ratings for Labcorp Holdings LH +2.25% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The following table ...

Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | ...

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Shares of Labcorp Holdings Inc. LH inched 0.34% higher to $229.92 Monday, on what proved to be an all-around mixed trading ...

The Federal Circuit on Monday, January 6, rejected Labcorp's argument that the Patent Trial and Appeal Board erred in its ...

A Louisiana patient who had been hospitalized with the first human case of highly pathogenic avian influenza, or H5N1, in ...

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent ...